At the 2022 AACR annual meeting, CRI scientists highlighted a wide scope of cancer immunology advances, and…
Day 4 of CICON19 highlighted breakthroughs in our understanding of the metabolic crosstalk within the tumor microenvironment as…
Day 3 of CICON19 explored current strategies to identify tumor neoantigens and develop vaccines as well as advances…